Positron Corporation
From Wikipedia, the free encyclopedia
Positron Corporation is an American nuclear medicine healthcare company specializing in cardiac Positron Emission Tomography (PET) imaging.[1][2] Positron is headquartered in Niagara Falls, New York in addition to its clinical and technical cardiovascular PET training facility.[3][4]
 | |
| Company type | Public |
|---|---|
| OTC Pink: POSC | |
| Industry | Healthcare |
| Founded | (1983) |
| Headquarters | , |
| Products | Nuclear medical PET imaging devices |
| Website | www |
The company's products and services enable healthcare providers to diagnose cardiac disease and improve patient outcomes.[3][5] Positron Corporation is a public company and traded on the Financial Industry Regulatory Authority, Inc.'s OTC Bulletin Board under the ticker symbol POSC.[4][6]
History
Positron was founded in 1983 as a research and development company.[7][8]
Company development
Summarize
Perspective
After its founding in 1983, Positron debuted a new time-of-flight tomograph called the POSICAM.[9] Posicam used barium fluoride for the scintillation detector and was primarily used by researchers interested in cardiac imaging.[9] In 1985, the FDA approved the POSICAM system for marketing and the following year, Positron began commercial operations.[10] The FDA later gave approval to Positron to begin marketing its HZ PET imaging system in 1991.[10] Positron received patents for aspects of its HZ and HZL POSICAM systems in 1993 along with FDA approval to market HZL.[11]
In 2005, Positron entered into a joint venture contract with Neusoft Medical Systems Co., Inc. of Shenyang, China for a jointly owned company to pursue the manufacturing of PET imaging equipment called Neusoft Positron Medical Systems Co. Ltd.[12][11] The following year, Positron acquired a manufacturer/developer of nuclear imaging devices called IS2 Medical Systems, Inc. based in Ontario, Canada.[13] Positron acquired DoseShield Corporation, a developer and manufacturer of automated radiopharmaceutical technology/systems in 2008.[14] In 2009, Positron and its partner Neusoft Medical Systems received FDA approval to sell and distribute their Attrius PET system.[15][16]
Attrius
The Attrius is Positron's main cardiac PET system that the company provides in nuclear medicine that was launched in 2010.[12] The system uses software to monitor coronary artery overlay display and open architecture for new protocol development and customization and motion correction.[17][18] Other products include PosiRx, a system that simplifies and controls the procedures associated with the preparation and delivery of radiopharmaceuticals used in molecular imaging and PosiStar, Positron's customer care plan for Attrius.[4]
Awards
- Positron Corporation is the winner of the 2010 North American Molecular Imagine Systems New Product Innovation Award given by the research firm Frost & Sullivan.[4]
References
Further reading
Wikiwand - on
Seamless Wikipedia browsing. On steroids.